Dennis Dencher is a seasoned global executive with over two decades of experience in the life science industry. He has an impressive track record of delivering strategic growth and turnarounds in highly competitive, complex, and regulated markets. Dencher has held various senior leadership positions, including Chief Commercial Officer at Orifarm Group, where he has full P&L responsibility for the Generics business and the Speciality Pharma Products, OTC, and Non-OTC portfolio, which he acquired from Takeda. He is also a co-owner and board member of ScandiSense ApS, an aspiring company building a leading web portal for physical and mental health through Sense Klubben.

Dencher has broad life-science and therapeutic experience in hearing and audio solutions, dermatology, thrombosis, anesthesia, women's health, and oncology. He has a solid experience with patient and healthcare professional services, launch of innovative products, DTC campaigns of OTCs, commercialization, and strategic growth of Branded Generics, Rx, and OTC in Secondary and Primary Care. Dencher operates at his strongest in a growth or turnaround context.

Dencher has a diploma in Pharmaceutical Sales and Marketing from the Scandinavian International Management Institute, completed a 2-year LEO Leadership Program in Strategic Leadership at IMD (International Institute for Management Development) - Business Programs, and holds a Bachelors in Commerce from Handelshøjskolen i København / Copenhagen Business School.